Orgenesis Announces Collaboration Agreement with Tel Aviv Sourasky Medical Center to Advance Point-of-Care Development and Commercialization of Cell and Gene and Therapies
Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, has entered into a collaboration agreement...
November 16, 2021
by FirstWordPharma
Orgenesis to Acquire Koglio Therapeutics
Will accelerate the commercialization of Koligo’s KYSLECEL, a personalized islet cell therapy available in the U.S. for chronic and recurrent acute pancreatitis.
October 9, 2020
by contractpharma
Orgenesis to Collaborate with Educell to Conduct Clinical Validation of Cell Therapies Using Orgenesis’ Proprietary POCare Technologies for the Generation and Expansion of T-Cells
GERMANTOWN, MD – July 14, 2020 – Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs).
August 12, 2020
by PharmaSources.com
Orgenesis Enters Collaboration Agreement with Educell
Orgenesis Inc., a global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs), has entered into a Collaboration Agreement with Educell Ltd., a European cell therapy company.
July 15, 2020
by contractpharma
Orgenesis to Acquire Tamir Bio Assets
Aims to combine ranpirnase antiviral platform with Bioxome technology for enhanced payload delivery directly to cells.
April 15, 2020
by contractpharma
Orgenesis, ExcellaBio Enter Cell Therapy Tie-up
Orgenesis, a developer, manufacturer and service provider of advanced cell therapies, has entered into a collaboration and licensing agreement with ...
April 18, 2019
by contractpharma
Orgenesis Enters Drug Devt. Collaboration with Ben-Gurion Univ.
Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, along with BGN Technologies and the National Institute for Biotechnology in the Negev (NIBN)......
August 24, 2018
by contractpharma